Both fusion analysis and DEG-based approaches consistently detect DUX4-r at a frequency of 5-10% in B-ALL cohorts [1, 2, 7, 52, 57, 59, 61, 63, 64, 74, 86, 87]. Here, DUX4 is linked to acute lymphoblastic leukemia.